Linda De Jesus, IDT Vice President and General Manager, Global Head of Commercial.

Research from the NIH’s National Cancer Institute, an agency beleaguered by funding cuts and censorship, finds that ...

Dealing with these decisions isn’t easy while undergoing cancer treatment. But yes, it’s completely understandable to ...

Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments and diagnostics easier and quicker, new research has found.

A new study reveals that air pollution, traditional herbal medicines and other environmental exposures are linked to genetic ...

Australians in their 30s and 40s are being diagnosed with cancer at unprecedented rates, with at least 10 types of the ...

The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.

Lung cancer cases are on the rise in non-smokers around the world, and air pollution could be an insidious, contributing ...

J&J has rights to niraparib in prostate cancer, and views the drug as a successor to Zytiga, once a $2.5 billion-a-year ...

Australians aged in their 30s and 40s are experiencing unprecedented and in some cases world-leading rates of 10 different ...

J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, ...